American Journal of Ophthalmology
Volume 138, Issue 6 , Pages 959-963, December 2004

Appositional suprachoroidal hemorrhage: A case-control study

Presented in part at ARVO 2002 in Ft. Lauderdale, Florida, and the Retina Congress 2002 in San Francisco, California.

  • Darius M. Moshfeghi, MD

      Affiliations

    • Stanford University Department of Ophthalmology, Stanford, California
    • Ronald G. Michels Fellowship Foundation, Baltimore, Maryland, Heed Fellowship.
    • ,
  • Brian Y. Kim, MD

      Affiliations

    • Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
    • ,
  • Peter K. Kaiser, MD

      Affiliations

    • Stanford University Department of Ophthalmology, Stanford, California
    • Corresponding Author InformationInquiries to Peter K. Kaiser, MD, Cole Eye Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk i3, Cleveland, OH 44195; fax: (216) 445-2226
    • ,
  • Jonathan E. Sears, MD

      Affiliations

    • Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
    • ,
  • Scott D. Smith, MD, MPH

      Affiliations

    • Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Accepted 2 July 2004. published online 05 November 2004.

Purpose

To identify the risk factors, prognostic factors, and clinical outcomes of patients with perioperative appositional suprachoroidal hemorrhage (ASCH).

Design

Case-control study.

Setting

Tertiary referral center.

Methods

Subjects included all patients with perioperative ASCH documented by B-scan ultrasound between May 1990 and March 2001. Two or three control patients were selected for each case, matched by surgeon, procedure, and date of surgery within 1 month. Surgery was performed as necessary. main outcome measures. The odds of ASCH associated with clinical risk factors. secondary outcome measure: visual acuity.

Results

Thirty-seven cases with ASCH were identified. Ninety-two procedure- and surgeon-matched control subjects (2.48:1) were selected. Twenty-six cases (71%) of ASCH were related to a glaucoma operation. Risk factors for the development of ASCH included previous vitrectomy (P = .003, odds ratio of 12) and older age (P = .007, odds ratio 1.57/decade of increasing age). Hypertension was found to be protective (P = .02, odds ratio of 0.33). Factors associated with a poor visual outcome in patients with ASCH included apposition >30 days (P = .01), history of uveitis (P = .04), history of dry age-related macular degeneration (P = .05), and history of extracapsular cataract extraction (P = .05). Median pre-ASCH visual acuity was 20/100, and final median visual acuity was 20/1600.

Conclusions

Risk factors for the development of ASCH include previous vitrectomy and older age. Patients with these risk factors should be informed of their greater chance of poor visual acuity and anatomic outcomes secondary to the development of ASCH.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Biosketch and/or additional material at ajo.com

PII: S0002-9394(04)00843-8

doi:10.1016/j.ajo.2004.07.002

American Journal of Ophthalmology
Volume 138, Issue 6 , Pages 959-963, December 2004

Article Tools